Freshly Printed - allow 7 days lead
Couldn't load pickup availability
Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors
Drug Discovery and Development
Ana Martinez (Edited by), A Martinez (Author), Ana Castro (Edited by), Miguel Medina (Edited by), Binghe Wang (Series edited by)
9780471770015, Wiley
Hardback, published 3 November 2006
384 pages
24.3 x 16.1 x 2.4 cm, 0.658 kg
Many researchers believe that GSK-3 and its inhibitors could lead to effective treatments for neurogenerative disorders, type II diabetes, depression and bipolar disorder, and some forms of cancer. This book provides a thorough introduction to GSK-3, presents up-to-date information, and mentions the birth of several chemical families of GSK-3 inhibitors with varying selectivity. It’s a great reference for researchers in drug design and development.
Foreword: The Origins of GSK-3. Preface. Acknowledgments. Contributors. Abbreviations. PART I: CELLULAR FUNCTIONS OF GSK-3. 1. Glycogen Synthase Kinase-3 - an Introductory Synopsis . 2. Glycogen-Synthase-Kinase-β (GSK-3β) a Key Signaling Enzyme: A Developmental Neurobiological Perspective. 3. Role of GSK3/Shaggy in neuronal cell biology. 4. The
Subject Areas: Chemistry [PN]
